Please login to the form below

Not currently logged in
Email:
Password:

Genentech

This page shows the latest Genentech news and features for those working in and with pharma, biotech and healthcare.

New biotech accelerator launched in Cambridge, UK

New biotech accelerator launched in Cambridge, UK

Keystone investors in the venture include Cambridge Innovation Capital, Babraham Bioscience Technologies, Genentech ( Roche’ s biotech arm), Dr Ian Tomlinson and Dr Jonathan Milner, co-founder and deputy chairman of antibody

Latest news

More from news
Approximately 7 fully matching, plus 230 partially matching documents found.

Latest Intelligence

  • Where next in Alzheimer’s disease R&D? Where next in Alzheimer’s disease R&D?

    Since 2012, AC Immune has partnered tau assets with Roche’s Genentech, Johnson &Johnson and Eli Lilly.

  • 30 Women Leaders in UK Healthcare (part 2) 30 Women Leaders in UK Healthcare (part 2)

    The strategic partnerships she has forged on Immunocore’s behalf with big pharma  companies have secured vital funding and allowed the company to grow – AstraZeneca, Genentech and GlaxoSmithKline have each signed

  • Tackling the challenge of non-adherence Tackling the challenge of non-adherence

    A 2016 Best Practices LLC survey of leading drug manufacturers including Genentech Baxter BioScience, GlaxoSmithKline, Boehringer Ingelheim and Teva Pharmaceutical Industries revealed that 40% already have a dedicated big data group.

  • Deal Watch - May 2017 Deal Watch - May 2017

    Peptidream has something going for it apart from speculative numbers.  It has signed deals with 10 companies in the last two years including Novartis, Genentech, Sanofi, Merck &Co and Lilly.  The

  • Holding on to hope for Alzheimer’s advances Holding on to hope for Alzheimer’s advances

    Positive results from a phase Ib dose-escalation study were presented and Roche’s Genentech unit is pushing on with its 60 mg/kg dose in a phase III trial of

More from intelligence
Approximately 0 fully matching, plus 26 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 26 partially matching documents found.

Latest from PMHub

  • Augmented Reality in patient communication – don’t miss out!

    Electronic Informed Consent Forms (e-ICFs) and Electronic Data Capture (EDC). In a recent well written article, Pierre Corin from Genentech discussed the drivers, advantages and possible challenges of using electronic ... References:. Pierre Corin,

  • It's time to change the conversation

    Changing the conversation with patients. One of the earliest adopters of technology and social media to change the conversation with patients, was Genentech. ... Starting from the position of caring about the patient, Genentech created the Herceptin

  • Top 7 Trends in Pharma Marketing for 2015

    Investment and utilisation of this tool is a trend that we expect to grow even more during 2015. Indeed, early Jan 2015 news that  Genentech, a member of the Roche Group,

  • Random42 Scientific Communication

    Genentech. Genzyme. Gilead. Grunenthal. GlaxoSmithKline. HCA Healthcare. Heron Therapeutics. Ignyta. Ironwood.

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health

Cello Health’s mission is to help our clients unlock the potential that exists with their assets, brands and organisations in...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics